newstock.ai
← Back

CICigna

$277.26-1.32%Real quote · delayedHealth insurance

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $274.9B · latest quarter up 6.7% YoY · profitable (FY net income $6.0B) · short activity above its recent average — bears adding.

FY revenue

$274.9B

2025-12

Latest Q YoY

+6.7%

FY net income

$6.0B

Diluted EPS

$22.33

Short volume

64.6%

20d avg 44.5% · shorts building

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

🎯 Market expectations

Expectation reliability High · 76/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$7.46Estimate range $7.44 ~ $7.48 · 7 analystsRevisions (4w):2
History: actual vs consensusavg +2.3%
  • Jun 2026$7.78 vs $7.58+2.64%
  • Mar 2026$7.79 vs $7.62+2.23%
  • Dec 2025$8.08 vs $7.87+2.67%
  • Sep 2025$7.83 vs $7.70+1.69%

The takeaway

It has tracked consensus closely — no systematic over- or under-shooting.

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

0 direct · 1 2nd-order · 0 thematic

Ranked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 16 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for nowvolume

📜 Call history (newest first

🔒 Pro only

16 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

Sign up · free 7-day trial →
🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.

Sign up · free 7-day trial →